List view / Grid view

Biosimilars

 

article

European Pharmaceutical Review Issue 3 2021

23 June 2021 | By

In this journal, features on the current regulatory positions on nitrosamine impurities, how investing in off-patent medicines can help drive innovation and why new regulations could lead to a biosimilar boom in the UK. Other articles include an exploration of the challenges in developing and delivering lipid nanoparticle mRNA-based vaccines,…